7Antonietta R. Farina,Lucia Cappabianca,Giuseppina DeSantis,Natalia Di Ianni,Pierdomenico Ruggeri,Marzia Ragone,Stefania Merolle,Kathryn F. Tonissen,Alberto Gulino,Andrew R. Mackay.Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cells[J].FEBS Letters.2011(20)
8Bingxiu Xiao,Junming Guo,Ying Miao,Zhen Jiang,Rong Huan,Yuanyuan Zhang,Dong Li,Jiuchang Zhong.Detection of miR-106a in gastric carcinoma and its clinical significance[J].Clinica Chimica Acta.2008(1)
9Taisuke Hosaka,Yasuaki Nakashima,Katsuyuki Kusuzaki,Hiroaki Murata,Tomitaka Nakayama,Takeharu Nakamata,Tomoki Aoyama,Takeshi Okamoto,Kohichi Nishijo,Nobuhito Araki,Tadao Tsuboyama,Takashi Nakamura,Junya Toguchida.A Novel Type of EWS-CHOP Fusion Gene in Two Cases of Myxoid Liposarcoma[J].The Journal of Molecular Diagnostics.2002(3)
10Angelo P. Dei Tos.Liposarcoma: New entities and evolving concepts[J].Annals of Diagnostic Pathology.2000(4)
6Ladanyi M, Bridge JA. Contribution of molecular genetic data to the classification of sarcoma. Hum Pathol,2000, 31:532-538.
7Perez-losada J, Pintado B, Gutierrez-Adan A, et al. The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice. Oncogene,2000,19 : 2413-2422.
8Kanoe H, Nakayama T, Hosaka T,et al. Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase Ⅱ in the process of translocation. Oncogene, 1999,18 :721-729.
9Hosaka T, Kanoe H, Nakayama T, et al. Translin binds to the sequences adjacent to the breakpoints of the TLS and CHOP genes in liposarcomas with translocation t( 12 ;6). Oncogene ,2000, 19:5821-5825.
10Sreekantaiah C, Karakousis CP, Leong SP, et al. Cytogenetic findings in liposarcoma correlate with histopathologic subtypes .Cancer, 1992, 69 : 2484-2495.
4Lee SY, Goh BK, Teo MC, et al. Retroperitoneal liposarcomas, the experience of a tertiary Asian center[J]. World J Surg Oncol, 2011,9 (1):12-13.
5Keung EZ, Horniek JL, Bertagnolli MM, et al. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery[J]. J Am Coil Surg,2014,218(2):206-217.
6Tateishi U, Hasegawa T, Beppu Y, et al. Primary dedifferentiated liposarcoma of the retroperitoneum. Prognostic significance of com- puted tomography and magnetic resonance imaging features [J]. J Comput Assist Tomogr,2003,27(5):799-804.
7Vajtai Z, Korngold E, Hooper JE, et al.Suprarenal retroperitoneal liposareoma with intracaval tumor thrombus: an imaging mimic of adrenocortical carcinoma[J]. Clin Imag, 2014,38( 1 ):75-77.
8Patil S, Chamberlain RS. Determinants of Iong-teml survival in well differentiated extremity and retroperitoneal liposarcoma: A population based outcomes study of 1,355 patients from the SEER database ( 1973-2008 ) [J]. J Surg Res,2013,179 (2) :305-306.
9Grobmyer SR, Wilson JP, Apel B, et al. Recurent retropefitoneal sarcoma:impact of biology and therapy on outcomes [J]. J Am Coil Surg,2010,2 I0 ( 5 ) :602-608.
